Promising Dividend Stocks To Follow Today - May 10th

Direxion Daily TSLA Bull 2X Shares, ProShares UltraPro Short QQQ, Texas Instruments, AbbVie, and Gilead Sciences are the five Dividend stocks to watch today, according to MarketBeat's stock screener tool. Dividend stocks are shares of companies that regularly distribute a portion of their profits to shareholders in the form of cash payments, known as dividends. They are often issued by well-established, financially stable firms seeking to provide investors with a steady income stream. Investors in dividend stocks typically value both the ongoing payouts and the potential for share-price appreciation over time. These companies had the highest dollar trading volume of any Dividend stocks within the last several days.

Direxion Daily TSLA Bull 2X Shares (TSLL)

Shares of TSLL stock traded up $0.96 on Friday, reaching $11.33. 250,258,753 shares of the company were exchanged, compared to its average volume of 90,269,717. The company has a 50-day moving average of $9.26 and a 200-day moving average of $18.26. The company has a market cap of $5.56 billion, a price-to-earnings ratio of 48.19 and a beta of -5.14. Direxion Daily TSLA Bull 2X Shares has a one year low of $6.29 and a one year high of $41.50.

Read Our Latest Research Report on TSLL

ProShares UltraPro Short QQQ (SQQQ)

ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.

ProShares UltraPro Short QQQ stock traded up $0.08 during mid-day trading on Friday, reaching $28.80. The stock had a trading volume of 75,770,632 shares, compared to its average volume of 52,759,609. ProShares UltraPro Short QQQ has a fifty-two week low of $26.21 and a fifty-two week high of $57.95. The stock's 50-day simple moving average is $36.44 and its 200-day simple moving average is $32.80.

Read Our Latest Research Report on SQQQ

Texas Instruments (TXN)

Texas Instruments Incorporated designs, manufactures, and sells semiconductors to electronics designers and manufacturers in the United States and internationally. The company operates through Analog and Embedded Processing segments. The Analog segment offers power products to manage power requirements across various voltage levels, including battery-management solutions, DC/DC switching regulators, AC/DC and isolated controllers and converters, power switches, linear regulators, voltage references, and lighting products.

TXN stock traded up $6.63 during midday trading on Friday, reaching $172.27. 8,655,053 shares of the company's stock traded hands, compared to its average volume of 6,225,065. The company has a quick ratio of 2.88, a current ratio of 4.12 and a debt-to-equity ratio of 0.76. The firm's fifty day moving average price is $167.29 and its 200-day moving average price is $185.22. Texas Instruments has a 52 week low of $139.95 and a 52 week high of $220.39. The company has a market cap of $156.50 billion, a price-to-earnings ratio of 33.19, a P/E/G ratio of 3.30 and a beta of 0.97.

Read Our Latest Research Report on TXN

AbbVie (ABBV)

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.

Shares of NYSE:ABBV traded down $1.28 during midday trading on Friday, hitting $184.30. 7,806,084 shares of the company's stock were exchanged, compared to its average volume of 6,122,857. The company has a debt-to-equity ratio of 17.94, a current ratio of 0.66 and a quick ratio of 0.55. AbbVie has a 12 month low of $153.58 and a 12 month high of $218.66. The company has a market cap of $326.02 billion, a PE ratio of 76.79, a price-to-earnings-growth ratio of 1.62 and a beta of 0.56. The stock has a 50 day moving average price of $194.23 and a 200-day moving average price of $187.23.

Read Our Latest Research Report on ABBV

Gilead Sciences (GILD)

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis.

GILD stock traded down $1.30 during mid-day trading on Friday, reaching $96.86. 13,140,489 shares of the company traded hands, compared to its average volume of 7,599,780. The stock has a market cap of $120.61 billion, a price-to-earnings ratio of 261.78, a P/E/G ratio of 0.71 and a beta of 0.26. Gilead Sciences has a fifty-two week low of $62.07 and a fifty-two week high of $119.96. The firm's 50 day moving average price is $107.23 and its 200 day moving average price is $99.23. The company has a quick ratio of 1.20, a current ratio of 1.50 and a debt-to-equity ratio of 1.24.

Read Our Latest Research Report on GILD

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.